Innovent Biologics (HK:1801) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Innovent Biologics has announced the grant of share options and restricted shares to certain employees under its 2024 Share Scheme. A total of 170,600 share options were granted to six grantees, and 683,400 restricted shares were granted to 16 grantees, all of whom are non-senior staff. These grants are subject to performance targets and have a clawback mechanism in case of misconduct or termination for cause.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.